The management of elevated blood pressure in acute stroke: Preferential use of angiotensin II receptor antagonists?

Journal of Hypertension

Volumn 22, Issue 5, 2004, Pages 877-878

  Strandgaard, Svend ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDAPAMIDE; LOSARTAN; PERINDOPRIL; VALSARTAN;

BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BRAIN; BRAIN ISCHEMIA; BRAIN PERFUSION; CLINICAL TRIAL; EDITORIAL; HUMAN; HYPERTENSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STROKE; TREATMENT OUTCOME;

EID: 2542475163     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200405000-00004     Document Type: Editorial

References (13)

1. Semplicini A, Maresca A, Boscolo G, Sartori M, Rocchi R, Giantin V, et al. Hypertension in acute ischemic stroke. A compenstory mechanism or an additional damaging factor? Arch Intern Med 2003; 163:211-216.
2. Blood Pressure in Acute Stroke Collaboration (BASC). Interventions for deliberately altering blood pressure in acute stroke (Cochrane Review). The Cochrane Library, issue 1. Chichester, UK: John Wiley & Sons; 2004.
3. Olsen TS, Larsen B, Herning M, Bech Skriver ER, Lassen NA. Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischemic penumbra in patients with acute stroke. Stroke 1983; 14: 332-341.
4. Barry DI, Jarden JO, Juhler M, Graham DI, Strandgaard S, Paulson OB. Cerebrovascular effects of converting enzyme inhibition. I: Effects of intravenous captopril in spontaneously hypertensive and normotensive rats. J Hypertens 1984; 2:589-597.
5. Vraamark T, Waldemar G, Strandgaard S, Paulson OB. The effect of the angiotensin II-receptor antagonist CV-11974 on cerebral blood flow autoregulation. J Hypertens 1995; 13:755-761.
6. Fischer Pedersen T, Paulson OB, Høj Nielsen A, Strandgaard S. Effect of nephrectomy and captopril on autoregulation of cerebral blood flow in rats. Am J Physiol Heart Circ Physiol 2003; 285:H1097-H1104.
7. Blood Pressure Lowering Trialists' Collaboration. Effects of different blood-pressure lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomised trials. Lancet 2003; 362:1527-1535.
8. PROGRESS Collaborative Group Randomised trial of a perindopril-based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-1041.
9. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al., for the LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction study (LIFE): a randomised trial against atenolol. Lancet 2002; 359:995-1003.
10. Julius S, Kjeldsen SE, Brunner H, Hansson L, Platt F, Ekman S, et al. VALUE trial: long-term blood pressure trends in 13 449 patients with hypertension and high cardiovascular risk. Am J Hypertens 2003; 16:544-548.
11. Schrader J, Luders S, Kulschewski A, Bergher J, Zidek W, Treib J, et al. Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group: the ACCESS study: evaluation of acute candesartan therapy in stroke survivors. Stroke 2003; 34:1699-1703.
12. Nazir FS, Overell JR, Bolster A, Hilditch TE, Reid JL, Lees KR. The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischemic stroke. J Hypertens 2004; 22:989-995.
13. Groth W, Blume A, Gohlke P, Unger T, Culman J. Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J Hypertens 2003; 21:2175-2182.